par C346 Pill - yellow capsule/oblong, 14mm
Pill with imprint par C346 is Yellow, Capsule/Oblong and has been identified as Memantine Hydrochloride Extended-Release 7 mg. It is supplied by Par Pharmaceutical, Inc.
Memantine is used in the treatment of Alzheimer's Disease and belongs to the drug class miscellaneous central nervous system agents. There is no proven risk in humans during pregnancy. Memantine 7 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for par C346
Memantine Hydrochloride Extended-Release
- Imprint
- par C346
- Strength
- 7 mg
- Color
- Yellow
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Miscellaneous central nervous system agents
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Par Pharmaceutical, Inc.
- National Drug Code (NDC)
- 10370-0346
- Inactive Ingredients
-
sucrose,
corn starch,
hydroxypropyl cellulose (type e),
magnesium silicate,
ethylcellulose,
triethyl citrate,
polyethylene glycol 3350,
titanium dioxide,
gelatin,
shellac,
ferrosoferric oxide,
FD&C Blue No. 2,
FD&C Red No. 40,
D&C Yellow No. 10,
FD&C Blue No. 1,
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
More about memantine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (90)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous central nervous system agents
- En español
Patient resources
- Memantine drug information
- Memantine (Advanced Reading)
- Memantine Tablets
- Memantine Extended-Release Capsules
- Memantine Solution
Other brands
Professional resources
- Memantine monograph
- Memantine (FDA)
- Memantine ER Tablets (FDA)
- Memantine ER capsules (FDA)
- Memantine Oral Solution (FDA)
- Memantine Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
